These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36510901)

  • 1. Endometrial serous carcinoma: A retrospective review of histological features & their clinicopathological association with disease-free survival & overall survival.
    Agarwal A; Yadav S; Dusane R; Menon S; Rekhi B; Deodhar KK
    Indian J Med Res; 2022 Jul; 156(1):83-93. PubMed ID: 36510901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
    Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
    Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
    van der Putten LJ; van de Vijver K; Bartosch C; Davidson B; Gatius S; Matias-Guiu X; McCluggage WG; Toledo G; van der Wurff AA; Pijnenborg JM; Massuger LF; Bulten J
    Virchows Arch; 2017 Jan; 470(1):63-68. PubMed ID: 27787595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF
    Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer?
    Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE
    Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer.
    Doghri R; Chaabouni S; Houcine Y; Charfi L; Boujelbene N; Driss M; Mrad K
    Mol Clin Oncol; 2018 Jul; 9(1):87-91. PubMed ID: 29896403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
    Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
    [No Abstract]   [Full Text] [Related]  

  • 12. Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases.
    Abdulfatah E; Sakr S; Thomas S; Al-Wahab Z; Mutch DG; Dowdy S; Bandyopadhyay S; Munkarah A; Elshaikh M; Morris R; Ali-Fehmi R
    Int J Gynecol Cancer; 2017 Oct; 27(8):1714-1721. PubMed ID: 28945214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
    Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study.
    Saatli B; Olgan S; Gorken IB; Uslu T; Saygili U; Dicle N; Cingillioglu B; Gumurdulu D; Guzel AB; Koyuncuoglu M
    Arch Gynecol Obstet; 2014 Jun; 289(6):1331-5. PubMed ID: 24435497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
    Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor free distance from serosa and survival rates of endometrial cancer patients: A meta-analysis.
    Pergialiotis V; Zachariou E; Vlachos DE; Vlachos A; Goula K; Thomakos N; Rodolakis A; Haidopoulos D
    Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():16-22. PubMed ID: 37167809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of myometrial invasion in endometrial carcinoma.
    Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
    Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.